An Analysis of the Procedure Volume and Geographic Distribution of US Urologists Performing Outpatient-Based Inflatable Penile Prosthesis Implantation

Introduction: This study described the procedure volume and geographic distribution of US urologists performing outpatient-based inflatable penile prosthesis (IPP) implantation. Methods: This retrospective administrative claims analysis from Definitive Healthcare identified urologists performing outpatient IPP implantation (Current Procedural Terminology 54405) on commercially insured or Medicare patients in 2021 in hospital outpatient settings. Procedural volumes for each implanter were calculated, and geographical analyses used their primary affiliated hospitals to identify the states in which the procedures were performed. Results: In 2021, 2049 urologists conducted 21,835 outpatient-based IPP procedures on a representative sample of commercially insured and Medicare patients, averaging 10.7 procedures per implanter annually. Procedural volumes were right-skewed: 8.6% of urologists performed 33.7% of procedures. Most urologists (91.4%) performed <20 cases. The highest volume implanters who performed more than 100 cases accounted for 6.3% of procedure volumes. Geographical analysis showed Florida (11.2%), California (7.8%), Texas (7.5%), New York (5.9%), Michigan (4.2%), Ohio (3.9%), and Georgia (3.9%) had the highest numbers of outpatient implanters, consistent with the top 7 states by IPP implantation volume (Florida [11.4%], Texas [9.4%], New York [6.5%], California [6.3%], Ohio [5.8%], Georgia [4.2%], and Michigan [3.4%]). Conclusions: Most urologists performing outpatient IPP (91.4%) performed <20 procedures per year in 2021. Less than 10% performed approximately one-third of the procedures. These findings highlight essential considerations for fostering development in the field of urology, particularly for emerging implanters aiming to expand patient outreach. The implications aim to establish a balanced and accessible landscape, benefiting both practitioners and the patients they serve.

Authors

Institutions

Publication Details

Journal
JU Open Plus
Published
2024-08-01
DOI
https://doi.org/10.1097/ju9.0000000000000190
Citations
1
Primary Topic
Sexual function and dysfunction studies
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Analysis of the Procedure Volume and Geographic Distribution of US Urologists Performing Outpatient-Based Inflatable Penile Prosthesis Implantation

Sirikan Rojanasarot, Kathryn Durand, William S. Du Comb
1 citations
JU Open Plus
Sexual function and dysfunction studies
0.39
article

An Analysis of the Procedure Volume and Geographic Distribution of US Urologists Performing Outpatient-Based Inflatable Penile Prosthesis Implantation

Sirikan Rojanasarot, Kathryn Durand, William S. Du Comb
article en
1 citations

Abstract

Introduction: This study described the procedure volume and geographic distribution of US urologists performing outpatient-based inflatable penile prosthesis (IPP) implantation. Methods: This retrospective administrative claims analysis from Definitive Healthcare identified urologists performing outpatient IPP implantation (Current Procedural Terminology 54405) on commercially insured or Medicare patients in 2021 in hospital outpatient settings. Procedural volumes for each implanter were calculated, and geographical analyses used their primary affiliated hospitals to identify the states in which the procedures were performed. Results: In 2021, 2049 urologists conducted 21,835 outpatient-based IPP procedures on a representative sample of commercially insured and Medicare patients, averaging 10.7 procedures per implanter annually. Procedural volumes were right-skewed: 8.6% of urologists performed 33.7% of procedures. Most urologists (91.4%) performed <20 cases. The highest volume implanters who performed more than 100 cases accounted for 6.3% of procedure volumes. Geographical analysis showed Florida (11.2%), California (7.8%), Texas (7.5%), New York (5.9%), Michigan (4.2%), Ohio (3.9%), and Georgia (3.9%) had the highest numbers of outpatient implanters, consistent with the top 7 states by IPP implantation volume (Florida [11.4%], Texas [9.4%], New York [6.5%], California [6.3%], Ohio [5.8%], Georgia [4.2%], and Michigan [3.4%]). Conclusions: Most urologists performing outpatient IPP (91.4%) performed <20 procedures per year in 2021. Less than 10% performed approximately one-third of the procedures. These findings highlight essential considerations for fostering development in the field of urology, particularly for emerging implanters aiming to expand patient outreach. The implications aim to establish a balanced and accessible landscape, benefiting both practitioners and the patients they serve.

JU Open PlusVol. 2(8)
Boston Scientific (United States) (US), Lahey Medical Center (US)
Partnerships for the goals
Openalex Percentile: Top 37%
Sexual function and dysfunction studies
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.